Tyler Stewart

Title(s)Assistant Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review. Res Rep Urol. 2023; 15:509-517. Meagher MF, Salmasi A, Stewart TF. PMID: 38025805; PMCID: PMC10655601.
      View in: PubMed   Mentions:
    2. The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers. Cancers (Basel). 2022 Dec 25; 15(1). Saidian A, Dolendo I, Sharabi A, Stewart TF, Rose B, McKay RR, Bagrodia A, Salmasi A. PMID: 36612124; PMCID: PMC9818005.
      View in: PubMed   Mentions: 2  
    3. Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System. JAMA Netw Open. 2022 11 01; 5(11):e2242048. Qiao EM, Guram K, Kotha NV, Voora RS, Qian AS, Ahn GS, Kalavacherla S, Pindus R, Banegas MP, Stewart TF, Johnson ML, Murphy JD, Rose BS. PMID: 36374497; PMCID: PMC9664263.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2022 12; 20(6):558-567. Talukder R, Makrakis D, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Jindal T, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Wright JL, Yu EY, Montgomery RB, Hsieh AC, Grivas P, Khaki AR. PMID: 36155169; PMCID: PMC10233855.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. Clin Genitourin Cancer. 2022 12; 20(6):515-523. Lee AM, Saidian A, Shaya J, Nonato T, Cabal A, Randall JM, Millard F, Stewart T, Rose B, Tamayo P, McKay RR. PMID: 35871039; PMCID: PMC10257153.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    6. Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma. Clin Genitourin Cancer. 2022 10; 20(5):e440-e452. Makrakis D, Talukder R, Lin GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, de Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, Lorenzo GD, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Jang A, Barata P, Sonpavde G, Yu EY, Montgomery RB, Grivas P, Khaki AR. PMID: 35778337; PMCID: PMC10257151.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials. Urol Oncol. 2022 05; 40(5):199.e15-199.e21. Javier-DesLoges J, Nelson TJ, Murphy JD, McKay RR, Stewart TF, Kader AK, Derweesh I, Martinez ME, Rose BS. PMID: 35431133; PMCID: PMC10441556.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    8. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):592-599. Qiao EM, Lynch JA, Lee KM, Kotha NV, Nalawade V, Voora RS, Qian AS, Nelson TJ, Yamoah K, Garraway IP, Stewart TF, Parsons JK, Rose BS. PMID: 34893859; PMCID: PMC9002290.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):600-608. Kotha NV, Kumar A, Qiao EM, Qian AS, Voora RS, Nalawade V, Karim Kader A, McKay RR, Stewart TF, Rose BS. PMID: 34918091; PMCID: PMC9002275.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer. Urol Oncol. 2022 06; 40(6):274.e1-274.e6. Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Rose BS, Stewart TF. PMID: 35216893; PMCID: PMC8863428.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance. J Natl Compr Canc Netw. 2022 02; 20(2):151-159. Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, Kumar A, Luterstein E, Yip AT, Nalawade V, Parsons JK, Kader AK, Stewart TF, Rose BS. PMID: 35130495; PMCID: PMC10399925.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin. Clin Genitourin Cancer. 2022 04; 20(2):165-175. Talukder R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lorenzo GD, Joshi M, Velho PI, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR. PMID: 35078711; PMCID: PMC8995351.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Analysis of CDK12 alterations in a pan-cancer database. Cancer Med. 2022 02; 11(3):753-763. Pan E, Cabal A, Javier-DesLoges J, Patel D, Panian J, Lee S, Shaya J, Nonato T, Xu X, Stewart T, Rose B, Shabaik A, Cohen E, Kurzrock R, Tamayo P, McKay RR. PMID: 34898046; PMCID: PMC8817093.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer. BJU Int. 2022 11; 130(5):592-603. Makrakis D, Talukder R, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Grant M, Lythgoe MP, Pinato DJ, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego LA, Duran I, Moses M, Barata P, Sonpavde G, Yu EY, Wright JL, Grivas P, Khaki AR. PMID: 34597472; PMCID: PMC10257152.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation. Adv Radiat Oncol. 2022 Jan-Feb; 7(1):100836. Kotha NV, Kumar A, Nelson TJ, Qiao EM, Qian AS, Voora RS, McKay RR, Stewart TF, Rose BS. PMID: 35071834; PMCID: PMC8767252.
      View in: PubMed   Mentions:
    16. Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in Advanced Larynx Cancer. Biomark Insights. 2021; 16:11772719211049848. Kotha NV, Voora RS, Qian AS, Kumar A, Qiao EM, Stewart TF, Rose BS, Orosco RK. PMID: 34658619; PMCID: PMC8512256.
      View in: PubMed   Mentions: 3  
    17. Patterns of Failure After Definitive Treatment of T4a Larynx Cancer. Otolaryngol Head Neck Surg. 2022 08; 167(2):274-285. Voora RS, Panuganti BA, Flagg M, Nelson T, Kotha NV, Qiao EM, Qian AS, Kumar A, Stewart TF, Rose B, Califano J, Weissbrod PA, Mell LK, Orosco RK. PMID: 34609937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men. J Natl Cancer Inst. 2021 10 01; 113(10):1343-1351. Klebaner D, Courtney PT, Garraway IP, Einck J, Kumar A, Martinez ME, McKay R, Murphy JD, Parada H, Sandhu A, Stewart T, Yamoah K, Rose BS. PMID: 33892497; PMCID: PMC8486332.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer Med. 2021 10; 10(20):7289-7297. Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, Durkin M, Vitzthum LK, Murphy JD, Stewart TF, Rose BS. PMID: 34528761; PMCID: PMC8525167.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men. Cancer. 2021 12 01; 127(23):4403-4412. Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, Kumar A, Luterstein E, Yip AT, Nalawade V, Parsons JK, Kader AK, Stewart TF, Rose BS. PMID: 34347291.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Analysis of the Prognostic Significance of Circulating Tumor DNA in Metastatic Castrate Resistant Prostate Cancer. Clin Genitourin Cancer. 2021 12; 19(6):564.e1-564.e10. Shaya J, Nonato T, Cabal A, Randall JM, Millard F, Stewart T, McKay RR. PMID: 34452870.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans. Eur Urol Open Sci. 2021 Aug; 30:1-10. Kumar A, Cherry DR, Courtney PT, Nalawade V, Kotha N, Riviere PJ, Efstathiou J, McKay RR, Karim Kader A, Rose BS, Stewart TF. PMID: 34337540; PMCID: PMC8317783.
      View in: PubMed   Mentions: 7  
    23. Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point. Clin Transl Radiat Oncol. 2021 May; 28:133-140. Kotha NV, Cherry DR, Bryant AK, Nalawade V, Stewart TF, Rose BS. PMID: 33997320; PMCID: PMC8089768.
      View in: PubMed   Mentions: 3  
    24. Association of race and health care system with disease stage and survival in veterans with larynx cancer. Cancer. 2021 08 01; 127(15):2705-2713. Voora RS, Kotha NV, Kumar A, Qiao EM, Qian AS, Panuganti BA, Banegas MP, Weissbrod PA, Stewart TF, Rose BS, Orosco RK. PMID: 33799314.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. BJU Int. 2021 08; 128(2):196-205. Esagian SM, Khaki AR, Diamantopoulos LN, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Santos VS, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt ME, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Msaouel P, Koshkin VS, Grivas P. PMID: 33556233.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    26. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021 02 01; 127(3):403-411. McKay RR, Sarkar RR, Kumar A, Einck JP, Garraway IP, Lynch JA, Mundt AJ, Murphy JD, Stewart TF, Yamoah K, Rose BS. PMID: 33036065.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    27. Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors. J Clin Oncol. 2020 09 20; 38(27):3088-3094. Gul A, Stewart TF, Mantia CM, Shah NJ, Gatof ES, Long Y, Allman KD, Ornstein MC, Hammers HJ, McDermott DF, Atkins MB, Hurwitz M, Rini BI. PMID: 32491962; PMCID: PMC7499610.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    28. Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations. Cancer Res. 2020 05 15; 80(10):2017-2030. Starrett JH, Guernet AA, Cuomo ME, Poels KE, van Alderwerelt van Rosenburgh IK, Nagelberg A, Farnsworth D, Price KS, Khan H, Ashtekar KD, Gaefele M, Ayeni D, Stewart TF, Kuhlmann A, Kaech SM, Unni AM, Homer R, Lockwood WW, Michor F, Goldberg SB, Lemmon MA, Smith PD, Cross DAE, Politi K. PMID: 32193290; PMCID: PMC7392201.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    29. Atezolizumab in understudied populations with bladder cancer. Nat Rev Urol. 2019 Aug; 16(8):449-450. Stewart TF, Petrylak DP. PMID: 31186524.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans